Published in Ren Fail on January 01, 2009
Estimating glomerular filtration rate: Cockcroft-Gault and Modification of Diet in Renal Disease formulas compared to renal inulin clearance. Clin J Am Soc Nephrol (2009) 2.12
IgA1-containing immune complexes in IgA nephropathy differentially affect proliferation of mesangial cells. Kidney Int (2005) 2.08
Procalcitonin levels in peritoneal dialysis patients. Perit Dial Int (2005) 1.46
[Investigation of tubular reabsorption of phosphates in patients with chronic kidney disease]. Vnitr Lek (2015) 1.38
IgA nephropathy: molecular mechanisms of the disease. Annu Rev Pathol (2012) 1.16
Cell-free plasma DNA during peritoneal dialysis and hemodialysis and in patients with chronic kidney disease. Ann N Y Acad Sci (2008) 1.02
IgA1 immune complexes from pediatric patients with IgA nephropathy activate cultured human mesangial cells. Nephrol Dial Transplant (2011) 0.99
The clinician and estimation of glomerular filtration rate by creatinine-based formulas: current limitations and quo vadis. Clin J Am Soc Nephrol (2011) 0.95
Relation between pH and the strong ion difference (SID) in body fluids. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub (2005) 0.92
IgA nephropathy: current views of immune complex formation. Contrib Nephrol (2007) 0.90
TH1-TH2 response and the atopy risk in patients with reproduction failure. Am J Reprod Immunol (2009) 0.83
IgA nephropathy: a clinical overview. Contrib Nephrol (2007) 0.83
Asymmetric dimethylarginine in hemodialysis, hemodiafiltration, and peritoneal dialysis. Artif Organs (2010) 0.83
Spontaneous jugular vein thrombosis. Acta Cardiol (2009) 0.83
Does treatment modality have an impact on anemia in patients with chronic renal failure? Effect of low- and high-flux biocompatible dialysis. Artif Organs (2002) 0.81
Reduction of plasma asymmetric dimethylarginine in obese patients with chronic kidney disease after three years of a low-protein diet supplemented with keto-amino acids: a randomized controlled trial. Wien Klin Wochenschr (2008) 0.81
Urinary transforming growth factor-β1 in children with obstructive uropathy. Nephrology (Carlton) (2011) 0.80
Citrate anticoagulation control by ionized calcium levels does not prevent hemostasis and complement activation during hemodialysis. Artif Organs (2007) 0.78
Effect of icodextrin-based dialysis solution on peritoneal leptin clearance. Perit Dial Int (2003) 0.78
Tissue factor, its inhibitor, and the thrombogenicity of two new synthetic membranes. Artif Organs (2005) 0.78
Urinary tract infections in pediatric renal transplant recipients--a two center risk factors study. Pediatr Transplant (2008) 0.77
Asymmetric dimethylarginine in obesity after renal transplantation. J Ren Nutr (2008) 0.77
Obesity and hyperhomocysteinaemia after kidney transplantation. Nephrol Dial Transplant (2003) 0.77
Estimated and measured donor creatinine clearance are poor predictors of long-term renal graft function and survival. Am J Transplant (2002) 0.77
Aortic stenosis severity is not a risk factor for poststenotic dilatation of the ascending aorta. Circ J (2007) 0.77
Tissue distribution and biological activities of immune complexes are determined by their size and composition. Nephrol Dial Transplant (2009) 0.77
The AN69 ST haemodialysis membrane under conditions of two different extracorporeal circuit rinse protocols a comparison of thrombogenicity parameters. Nephrol Dial Transplant (2007) 0.77
Enhanced metabolic effect of erythropoietin and keto acids in CRF patients on low-protein diet: Czech multicenter study. Am J Kidney Dis (2003) 0.76
Cell-free plasma DNA during Hemodialysis. Ren Fail (2009) 0.76
Asymmetric dimethylarginine and adiponectin after renal transplantation: role of obesity. J Ren Nutr (2008) 0.76
The relationship between estimated GFR based on the CKD-EPI formula and renal inulin clearance in potential kidney donors. Clin Nephrol (2014) 0.75
Tissue factor, its pathway inhibitor, and metabolic disturbances in long-term peritoneal dialysis. Kidney Blood Press Res (2003) 0.75
Importance of serum [Na+] and [Cl-] difference in acid-base status classification. Anesth Analg (2010) 0.75
[The most recent aspects of diagnosis and therapy of hyponatraemia]. Vnitr Lek (2015) 0.75
The use of sodium-chloride difference and chloride-sodium ratio in the evaluation of metabolic acidosis in critically ill patients. Eur J Pediatr (2012) 0.75
Peritoneal clearance and transport of procalcitonin. Ther Apher Dial (2009) 0.75
Development of peritoneal dialysis and renal replacement therapy in the Czech Republic since the postcommunist transition. Perit Dial Int (2007) 0.75
[Granulomatosis with polyangiitis manifested as diabetes insipidus]. Vnitr Lek (2016) 0.75
Metabolic syndrome after renal transplantation. Med Pregl (2007) 0.75
[Disorders of water and electrolyte metabolism and changes in acid-base balance in patients with ascitic liver cirrhosis]. Cas Lek Cesk (2017) 0.75
Fibrinolysis defect in long-term hemodialysis patients with type 2 diabetes mellitus and its relation to metabolic disorders. Am J Nephrol (2002) 0.75
[Metabolic acidosis in chronic kidney disease]. Vnitr Lek (2016) 0.75
A case study on peritoneal dialysis with biocompatible peritoneal dialysis fluid: increase in submesothelial compact zone thickness but not vessel density. Ther Apher Dial (2010) 0.75
[Present possibilities of monitoring the effectiveness of hyponatremia therapy]. Vnitr Lek (2016) 0.75
[The difference and ratio between serum concentrations of natrium and chlorides in patients with hyponatremia]. Vnitr Lek (2016) 0.75
[Systemic and intraperitoneal inflammation in peritoneal dialysis patients]. Vnitr Lek (2016) 0.75
[Clinical evaluation of acid-base status: Henderson-Hasselbalch, or Stewart-Fencl approach?] Cas Lek Cesk (2016) 0.75
Effects of high-tone external muscle stimulation on renal function in healthy volunteers. Clin Nephrol (2013) 0.75
Computed tomography-based assessment of bone mineral density in patients treated with peritoneal dialysis. Perit Dial Int (2004) 0.75
Early-morning urine osmolality in patients with chronic allograft nephropathy. Transpl Int (2004) 0.75
[Serum concentration and tubular resorption of sodium and chloride in patients with chronic renal disease]. Cas Lek Cesk (2015) 0.75